KBC Group’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
KBC Group's RDY Position: Q3 2026 in Review
KBC Group increased its Dr. Reddy's Laboratories (RDY) stake by 11% in Q3 2026, buying an estimated $8.53K and bringing the position to 7,236 shares worth $91K. The position accounts for ﹤0.01% of the portfolio, ranked #1447.
KBC Group first reported a position in RDY in Q2 2013 and has held it in 8 quarters since. The position peaked at $323K in Q3 2013. 232 funds tracked by Wall St. Rank hold RDY as of Q3 2026.
- KBC Group held 7,236 shares of Dr. Reddy's Laboratories worth $91K as of Q3 2026.
- KBC Group bought 689 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $8.53K.
- Dr. Reddy's Laboratories made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1447 holding.
- KBC Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 8 quarters since.
- KBC Group's Dr. Reddy's Laboratories position peaked at $323K in Q3 2013.
- 232 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.